The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

  title={The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease},
  author={Darius Sorbi and Jessica Boynton and Keith D. Lindor},
  journal={American Journal of Gastroenterology},
OBJECTIVE:The ratio of aspartate aminotransferase (AST) to alanine aminotransferase (ALT) is often greater than 2:1 in alcoholic hepatitis. The purpose of this study was to determine whether this ratio may be used to distinguish nonalcoholic steatohepatitis (NASH) from alcoholic liver disease.METHODS:Patients with NASH were matched with controls with alcoholic liver disease based on age, gender, and date of diagnosis. The diagnosis of alcoholic liver disease was based on exclusion of other… 

Figures and Tables from this paper

A study of alanine aminotransferase - aspartate aminotransferase as a marker of advanced alcoholic liver disease

Most of the patients with heavy alcohol drinking had high AST and alt levels, but ratio of AST/ALT levels was significant high and suggest chronic liver disease secondary to alcohol.

The ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT): the correlation of value with underlying severity of alcoholic liver disease.

The higher value of AST/ALT ratio is indicative of more severe liver damage due to alcohol.

[The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis].

The AST/ALT rate seems to be useful in the differential diagnosis of liver diseases, while lower than 1 is highly suggestive of nonalcoholic steatohepatitis.

Correlation between Aminotransferase Ratio (AST/ALT) and Other Biochemical Parameters in Chronic Liver Disease of Viral Origin

A significant positive correlation between AST/ALT with prothrombin time in CLD subjects without cirrhosis is found.

Utility of a new model to diagnose an alcohol basis for steatohepatitis.

ANI performance characteristics were significantly better than several conventional and recently proposed biomarkers used to differentiate ALD from NAFLD, including the histopathologic marker protein tyrosine phosphatase 1b, AST/ALT ratio, gamma-glutamyl transferase, and carbohydrate-deficient transferrin.

High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking.

Most patients with high alcohol consumption but without severe liver disease do not have an AST/ALT ratio above 1.0, which suggests advanced alcoholic liver disease, but high AST-ALT ratio suggests advanced alcohol-related liver cirrhosis.

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

The prevalence of nonalcoholic fatty liver disease has increased in the general population, especially in males, and there is a linear relationship between the prevalence of NAFLD and various metabolic parameters, even in nonobese subjects.

The Significance of Transaminases and Deritis Ratio for Predicting Alcoholic Liver Disease: A Hospital Based Comparative Study in Western Nepal

The estimation of deritis ratio is useful for the rational understanding of the extent of damage in alcoholic liver disease, and the importance of which is magnified by its widespread use.


AST: ALT ratio can be useful in differentiating the liver diseases and was observed when comparison was done between any two of the disease groups.

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD

ANI can help distinguish ALD from NAFLD with high accuracy; when ANI was combined with GGT, its effectiveness improved further.



AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

The AST/ALT ratio is a dependable marker of fibrosis stage and cirrhosis in patients with chronic HCV infection.

Carbohydrate-deficient transferrin as a marker of alcohol consumption in male patients with liver disease.

Investigation of the usefulness of CDT as a marker of alcohol consumption in patients with liver disease concluded that serum CDT is a good marker of alcoholism and is less influenced than the currently used biochemical markers for associated liver disease.

The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

In individual patients, poorly controlled diabetes and rapid weight loss preceded the onset of steatohepatitis, and in the patients with extensive fibrosis the the liver disease evolved from one of active inflammation to one of inactive cirrhosis without fat or inflammation.

Investigation of alcoholic liver disease.

  • G. Bird
  • Medicine
    Bailliere's clinical gastroenterology
  • 1993

Nonalcoholic Steatohepatitis

The epidemiology, pathogenesis, clinical features, histology, clinical course, diagnosis, and management of NASH are critically examined and the clinical relevance of the condition is determined.

Nonalcoholic steatohepatitis.

Pathology of alcoholic liver disease.

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Findings in 20 patients with nonalcoholic steatohepatitis of unknown cause found the patients were moderately obese, and many had obesity-associated diseases, such as diabetes mellitus and cholelithiasis.

Clinical features of alcoholic liver disease.

  • N. Finlayson
  • Medicine
    Bailliere's clinical gastroenterology
  • 1993